Alveo Technologies Announces Partner Program and Portal, New Enablement Software Suite, Further Empowering Partners in Co-Development of Advanced Molecular Diagnostics
11.7.2023 16:45:00 EEST | Business Wire | Press release
Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, today launched a web-based partner portal and suite of enablement software tools to further drive innovative partnerships onto the platform to co-develop and commercialize rapid, point of need diagnostic solutions across multiple life sciences industry sectors. Furthermore, its newest partnership with the Fraunhofer Institute for Cell Therapy and Immunology IZI extends the platform into the large animal veterinary sector. The institute belongs to the Fraunhofer-Gesellschaft, the world’s leading applied research organization.
Alveo has developed a rapid, handheld, reusable, and rugged multiplexed platform that pairs advanced molecular assays with cloud-enabled data analytics for highly accurate and sensitive real-time disease, pathogen and contaminant detection, analysis, and diagnosis. It utilizes Alveo’s globally patented loop-mediated isothermal amplification (LAMP) method for the direct electrical sensing of nucleic acid amplification. This portable molecular lab can deliver rapid testing at the point of need, for example, in doctor’s offices for various infectious diseases, in the field for crop testing, or on farms for livestock testing.
“True to our open-platform philosophy toward innovation, and our vision of making advanced molecular testing universally accessible, we are pleased to launch a web portal and software enablement suite that facilitates our current collaborations and opens the door to future partnerships across many new and underserved markets,” says Alveo CEO Shaun Holt. “We aim to work smarter to bring novel, accurate, and affordable molecular diagnostics to the point of need where actionable insights and outcomes can be significantly improved.”
“Alveo’s be.well™ platform is helping to solve some of the world’s toughest challenges in terms of healthcare access, food security, water and sanitation, and with future pandemic prevention measures,” Holt says.
In its mission to enable earlier detection of pathogens at the point of need, leveraging its open-platform approach, Alveo has partnered with companies in multiple industries around the world to co-develop and commercialize rapid molecular testing capabilities. Alveo’s phased partnerships can range from months to years depending upon the complexity and number of applications of interest. Depending on the extent of a partner’s in-house capabilities, Alveo can either complete the entire test development process with market and technical domain expertise from the partner in a Supported Partnership model, or lend its be.well™ expertise to the partner’s own research and development of assays in a Self-sufficient Partnership. The Partnership Portal facilitates collaboration and gives partners access to all research, training, and development resources required to bring a molecular diagnostic to market.
Fraunhofer IZI, based in Germany, is a world leader in the life sciences and with LAMP technology. Using Alveo’s be.well platform, Fraunhofer IZI will design novel assays within the veterinary space drawing on its deep experience in this area.
“We are impressed with the near-limitless possibilities of Alveo’s be.well™ platform and look forward to collaborating to build out their library of tests,” said Dr. Dirk Kuhlmeier, Head of the Diagnostics Department, Fraunhofer Institute of Cell Therapy and Immunology IZI. “Diagnostics is one of the four areas of focus for Fraunhofer Health and moving testing closer to the point of need is a strategic imperative for us.”
Partnership phases include defining the market and product requirements, primer screening and assay development, and transfer of the assay to the be.well™ Cartridge where it is optimized and validated through testing on Alveo’s IMPACT™ data analysis and testing software suite. Clinical trials and/or field studies are then conducted to verify the assay and validate the platform, Alveo develops and launches the be.well™ Mobile App, the partners collaborate on commercialization plans and Alveo manufactures the product.
Fraunhofer IZI joins a roster of commercialization partners including Barbados Investment and Development Corporation (Export Barbados (BIDC)), which brings the Caribbean nation’s top scientists and life sciences leaders into collaboration with Alveo in designing new assays in the areas of infectious disease, agriculture, veterinary, food, medicine, and aquaculture testing. Alveo has also partnered with agricultural sector leaders to design crop- and animal-specific assays to detect and analyze an even broader range of pathogens within the agricultural space, in the field, in real time.
About Alveo
At Alveo, we strive to improve outcomes by making molecular detection and diagnostics universally accessible – whether that means in the home, on the farm, in the clinic, or even within industrial processes. We understand the value of detecting pathogens earlier where decisions and results can be most effective and impactful. Alveo’s be.well™ platform technology encompasses a unique method of nucleic acid amplification coupled with our proprietary direct electrical sensors, enabling improved outcomes across numerous market sectors and verticals at the point of need. Our platform was designed from the bottom up to enable detection and diagnosis of pathogens earlier given its portability, ease of use, robust and rugged design, multiplexing capability, high accuracy, coupled with fast times to result. Cloud connected and Bluetooth enabled, advanced data and analytics are available for reportable diseases, and monitoring and surveilling of new and emerging pathogens. Our aim is to help customers and patients prevent or significantly limit the negative, destructive impact viruses, fungi, bacteria, and other pathogens can have on our planet. In doing so, we are providing actionable insights at lightspeed, improving health outcomes, saving time, reducing cost, and improving yields. With Be.well™, we Know Sooner, Act Faster™.
To learn more, visit https://alveotechnologies.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230711477764/en/
Contact information
Staci Vernick for Alveo Technologies, Inc.
SL Vernick Communications
610-812-6092/svernick@comcast.net
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Midas Atlantic Partners, in Partnership With the Najafi Companies, Has Entered Into a Put Option Agreement With Sylvamo Relating to the Potential Acquisition of Its European Operations6.11.2026 13:04:00 EET | Press release
Midas Atlantic Partners (“Midas Atlantic”), in partnership with The Najafi Companies, has signed a put option agreement with Sylvamo Corporation (“Sylvamo”) relating to the potential acquisition of its European operations (the “Business”). The transaction comprises Sylvamo’s uncoated freesheet paper mills in Saillat and Nymölla, as well as its forestry and supporting business operations across Europe. Closing is expected in the first quarter of 2027, once the required consultation processes are completed and regulatory approvals are obtained. The Business is a leading European producer of uncoated woodfree (UWF) paper for office and commercial printing. Its product portfolio spans cut-size office paper, sold under its own brands such as REY and Multicopy as well as on behalf of major OEM and office supplies customers, and paper reels for commercial printers and converters. Headquartered in Belgium, with two large-scale, vertically integrated pulp and paper mills, it serves a longstandi
Suzano Reports 36% Increase in Third Quarter Net Revenue Following Consolidation of Arbex6.11.2026 01:23:00 EET | Press release
Suzano (B3: SUZB3 / NYSE: SUZ) , the world’s largest pulp producer, announces its results for the third quarter of 2026 (3Q26), which for the first time include Arbex, the joint venture between Suzano and Kimberly-Clark established in July this year. Driven primarily by the consolidation of Arbex’s contribution, Suzano reported net revenue of BRL16.5 billion, an increase of 36% on the same period last year and a new quarterly record in the company’s 102-year history. Adjusted EBITDA totaled R$5.7 billion in 3Q26, up 9% on the same basis of comparison. Operating cash generation reached R$3.8 billion, an increase of 12%. Net income totaled R$2.1 billion. As announced following the completion of the transaction with Kimberly-Clark, Suzano holds a 51% equity interest in Arbex and will therefore fully consolidate the joint venture’s financial statements from this quarter onwards.1 “This quarter marks the beginning of a new phase for Suzano. With Arbex, we are now a broader business, both ge
iQmetrix Unveils Built-In Intelligence for Every Role in Telecom Commerce at Its 2026 Telecom Industry Address5.11.2026 23:39:00 EET | Press release
iQmetrix, the global provider of Intelligent Commerce Operating Systems for telecom, last week shared highlights from its 2026 Telecom Industry Address and Product Announcements, held virtually on Oct. 28 in two sessions, one for North American audiences and one for European audiences. The address was built around one theme: intelligence. Telecom commerce is moving from systems that record the business to systems that act on it, and the announcements put that intelligence in the hands of every role, from the sales associate at the counter, to the finance manager in the back office, to the corporate view leading the channel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105003162/en/ "Right now telecom providers are competing in a race to the bottom on price that no one wins. The way out is intelligence. Not AI bolted onto a fragmented tech stack, but intelligence built into how commerce runs. Information plus
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.11.2026 23:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to nine newly hired non-executive employees. The equity awards were granted on November 2, 2026, and consisted of options to purchase an aggregate of 59,275 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 28,200 shares. These options have an exercise price per share equal to $8.41, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted s
Graco QUANTM i230 Brings Electrification to High-Flow Fluid-Transfer Applications5.11.2026 23:16:00 EET | Press release
Graco Inc. is helping manufacturers electrify high-flow fluid-transfer applications with the global launch of the 3-inch QUANTM® i230, bringing efficient electric drive technology to demanding processes that have traditionally relied on pneumatic pumps. Paint, coatings and ceramics manufacturers depend on diaphragm pumps for their flexibility, reliability and ability to handle challenging materials. But pneumatic pumps also depend on compressed air — an energy-intensive plant resource whose available capacity can fluctuate as demand changes across a facility. The QUANTM i230 gives manufacturers another option for qualified high-flow applications. By combining familiar diaphragm pump capabilities with electric operation, the pump helps manufacturers move more material, reduce transfer bottlenecks and lower energy consumption by up to 80% compared to pneumatic pumps, while maintaining operating flexibility. “High-flow processes in industries like paint, coatings and ceramics have continu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom